Patients aged 75 years or older who are not immunocompromised should receive a protein subunit respiratory syncytial virus (RSV) vaccine, according to new recommendations from the American College of ...

Based on two test negative case control studies in immunocompromised adults, RSV vaccination was associated with a 70% reduction in RSV-associated hospitalization (95% CI: 66–73%). Indirect evidence ...

The American College of Physicians (ACP) issued updated vaccine practice points for physicians that advise adults aged 75 or older should receive a protein subunit Respiratory Syncytial Virus (RSV) ...

The American Academy of Pediatrics generally recommends RSV immunization for infants under eight months old born during or entering their first RSV season if their mothers weren’t vaccinated during ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Every fall and winter, a familiar set of illnesses makes ...

Older adults and people with certain medical conditions are more likely to receive the respiratory syncytial virus (RSV) vaccine, a new study finds. The report also showed that people in long-term ...

The CDC's Advisory Committee on Immunization Practices (ACIP) voted 14-0, with one abstention, on Wednesday to recommend that high-risk patients ages 50 to 59 be vaccinated for respiratory syncytial ...

This article is part of “Innovations In: RSV,” an editorially independent special report that was produced with financial support from MSD, Sanofi and AstraZeneca. Susan Green developed a stubborn ...

Flu, Covid, RSV and HMPV rising in NJ? Here's what to know about human metapneumovirus symptoms and why there may be no treatment. Is it serious?

Researchers in China recently published a study in Science Translational Medicine describing a new antibody cocktail for ...